Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

  1. Makrakis, D.
  2. Talukder, R.
  3. Lin, G.I.
  4. Diamantopoulos, L.N.
  5. Dawsey, S.
  6. Gupta, S.
  7. Carril-Ajuria, L.
  8. Castellano, D.
  9. de Kouchkovsky, I.
  10. Koshkin, V.S.
  11. Park, J.J.
  12. Alva, A.
  13. Bilen, M.A.
  14. Stewart, T.F.
  15. McKay, R.R.
  16. Tripathi, N.
  17. Agarwal, N.
  18. Vather-Wu, N.
  19. Zakharia, Y.
  20. Morales-Barrera, R.
  21. Devitt, M.E.
  22. Cortellini, A.
  23. Fulgenzi, C.A.M.
  24. Pinato, D.J.
  25. Nelson, A.
  26. Hoimes, C.J.
  27. Gupta, K.
  28. Gartrell, B.A.
  29. Sankin, A.
  30. Tripathi, A.
  31. Zakopoulou, R.
  32. Bamias, A.
  33. Murgic, J.
  34. Fröbe, A.
  35. Rodriguez-Vida, A.
  36. Drakaki, A.
  37. Liu, S.
  38. Lu, E.
  39. Kumar, V.
  40. Lorenzo, G.D.
  41. Joshi, M.
  42. Isaacsson-Velho, P.
  43. Buznego, L.A.
  44. Duran, I.
  45. Moses, M.
  46. Jang, A.
  47. Barata, P.
  48. Sonpavde, G.
  49. Yu, E.Y.
  50. Montgomery, R.B.
  51. Grivas, P.
  52. Khaki, A.R.
  53. Montrer des auteurs +
Revue:
Clinical Genitourinary Cancer

ISSN: 1938-0682 1558-7673

Année de publication: 2022

Volumen: 20

Número: 5

Pages: e440-e452

Type: Article

DOI: 10.1016/J.CLGC.2022.06.001 GOOGLE SCHOLAR